CCDC14-ADAM19 Fusion FISH Probe
The CCDC14-ADAM19 Fusion FISH Probe is used to confirm a fusion of the CCDC14 and ADAM19 genes. The fusion of the CCDC14 and ADAM19 genes has been associated with Breast Invasive Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
SKU | Test Kits | Buffer | Dye Color | Order Now |
---|---|---|---|---|
CCDC14-ADAM19-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL | ||
CCDC14-ADAM19-20-RERE | 20 (40 μL) | 200 μL | ||
CCDC14-ADAM19-20-REOR | 20 (40 μL) | 200 μL | ||
CCDC14-ADAM19-20-REGO | 20 (40 μL) | 200 μL | ||
CCDC14-ADAM19-20-REGR | 20 (40 μL) | 200 μL | ||
CCDC14-ADAM19-20-REAQ | 20 (40 μL) | 200 μL | ||
CCDC14-ADAM19-20-ORRE | 20 (40 μL) | 200 μL | ||
CCDC14-ADAM19-20-OROR | 20 (40 μL) | 200 μL | ||
CCDC14-ADAM19-20-ORGO | 20 (40 μL) | 200 μL | ||
CCDC14-ADAM19-20-ORAQ | 20 (40 μL) | 200 μL | ||
CCDC14-ADAM19-20-GORE | 20 (40 μL) | 200 μL | ||
CCDC14-ADAM19-20-GOOR | 20 (40 μL) | 200 μL | ||
CCDC14-ADAM19-20-GOGO | 20 (40 μL) | 200 μL | ||
CCDC14-ADAM19-20-GOGR | 20 (40 μL) | 200 μL | ||
CCDC14-ADAM19-20-GOAQ | 20 (40 μL) | 200 μL | ||
CCDC14-ADAM19-20-GRRE | 20 (40 μL) | 200 μL | ||
CCDC14-ADAM19-20-GROR | 20 (40 μL) | 200 μL | ||
CCDC14-ADAM19-20-GRGO | 20 (40 μL) | 200 μL | ||
CCDC14-ADAM19-20-GRGR | 20 (40 μL) | 200 μL | ||
CCDC14-ADAM19-20-GRAQ | 20 (40 μL) | 200 μL | ||
CCDC14-ADAM19-20-AQRE | 20 (40 μL) | 200 μL | ||
CCDC14-ADAM19-20-AQOR | 20 (40 μL) | 200 μL | ||
CCDC14-ADAM19-20-AQGO | 20 (40 μL) | 200 μL | ||
CCDC14-ADAM19-20-AQGR | 20 (40 μL) | 200 μL | ||
CCDC14-ADAM19-20-AQAQ | 20 (40 μL) | 200 μL |
ADAM19 Gene Summary
This gene encodes a member of the ADAM (a disintegrin and metalloprotease domain) family. Members of this family are membrane-anchored proteins structurally related to snake venom disintegrins and have been implicated in a variety of biological processes involving cell-cell and cell-matrix interactions, including fertilization, muscle development, and neurogenesis. This member is a type I transmembrane protein and serves as a marker for dendritic cell differentiation. It has been demonstrated to be an active metalloproteinase, which may be involved in normal physiological processes such as cell migration, cell adhesion, cell-cell and cell-matrix interactions, and signal transduction. It is proposed to play a role in pathological processes, such as cancer, inflammatory diseases, renal diseases, and Alzheimer's disease. [provided by RefSeq, May 2013]
Gene Name: ADAM Metallopeptidase Domain 19
Chromosome: CHR5: 156904311 -157002783
Locus: 5q33.3
CCDC14 Gene Summary
The Coiled-coil Domain Containing 14 (CCDC14) gene is located on chr3 :123632273-123680255 at 3q21.1.
Gene Name: Coiled-coil Domain Containing 14
Chromosome: CHR3: 123632273 -123680255
Locus: 3q21.1
Gene Diseases
The CCDC14 ADAM19 Fusion has been associated with the following diseases:
Disease Name |
---|
Breast Invasive Carcinoma |
FISH Probe Protocols
Protocol, Procedure, or Form Name | Last Modified | Download |
---|